Lenalidomidum
45 medicamente autorizate în România conțin substanța activă Lenalidomidum.
Ce este Lenalidomidum?
Lenalidomidum este o substanță activă (DCI - Denumire Comună Internațională) din clasa terapeutică Lenalidomide (cod ATC L04AX04). Acțiunea terapeutică principală: Imunosupresoare Alte Imunosupresoare. În nomenclatorul ANM România sunt autorizate 45 produse medicamentoase care conțin Lenalidomidum ca substanță activă.
Formele farmaceutice disponibile: caps..
Informațiile de pe această pagină provin din nomenclatorul oficial ANM. Consultați medicul sau farmacistul pentru recomandări personalizate.
Proprietăți chimice
Sursă: PubChem (NIH) · CID 216326
- Formula moleculară
- C13H13N3O3
- Greutate moleculară
- 259.2600 g/mol
- Număr CAS
- 191732-72-6
- InChIKey
- GOTYRUGSSMKFNF-UHFFFAOYSA-N
- Denumire IUPAC
- 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
- Alte denumiri
- Lenalidomide, Revlimid, Revimid, 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione, CC-5013, 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-, CDC 501, CDC-501
| Denumire comercială | Concentrație | Formă farmaceutică | Producător | Cod ATC | Prospect |
|---|---|---|---|---|---|
| LENALIDOMIDA ALKALOID-INT 10 mg | 10mg | Caps. | Alkaloid-Int D.o.o. - Slovenia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA ALKALOID-INT 15 mg | 15mg | Caps. | Alkaloid-Int D.o.o. - Slovenia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA ALKALOID-INT 25 mg | 25mg | Caps. | Alkaloid-Int D.o.o. - Slovenia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA ALKALOID-INT 5 mg | 5mg | Caps. | Alkaloid-Int D.o.o. - Slovenia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA GRINDEKS 10 mg | 10mg | Caps. | As Grindeks - Letonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA GRINDEKS 15 mg | 15mg | Caps. | As Grindeks - Letonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA GRINDEKS 2,5 mg | 2,5mg | Caps. | As Grindeks - Letonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA GRINDEKS 20 mg | 20mg | Caps. | As Grindeks - Letonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA GRINDEKS 25 mg | 25mg | Caps. | As Grindeks - Letonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA GRINDEKS 5 mg | 5mg | Caps. | As Grindeks - Letonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA GRINDEKS 7,5 mg | 7,5mg | Caps. | As Grindeks - Letonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA LABORMED 10 mg | 10mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA LABORMED 15 mg | 15mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA LABORMED 25 mg | 25mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA LABORMED 5 mg | 5mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA SANDOZ 10 mg | 10mg | Caps. | Synthon Hispania, S.l. - Spania | L04AX04 | 📄 Prospect |
| LENALIDOMIDA SANDOZ 15 mg | 15mg | Caps. | Synthon Hispania, S.l. - Spania | L04AX04 | 📄 Prospect |
| LENALIDOMIDA SANDOZ 2,5 mg | 2,5mg | Caps. | Synthon Hispania, S.l. - Spania | L04AX04 | 📄 Prospect |
| LENALIDOMIDA SANDOZ 20 mg | 20mg | Caps. | Synthon Hispania, S.l. - Spania | L04AX04 | 📄 Prospect |
| LENALIDOMIDA SANDOZ 25 mg | 25mg | Caps. | Synthon Hispania, S.l. - Spania | L04AX04 | 📄 Prospect |
| LENALIDOMIDA SANDOZ 5 mg | 5mg | Caps. | Synthon Hispania, S.l. - Spania | L04AX04 | 📄 Prospect |
| LENALIDOMIDA SANDOZ 7,5 mg | 7,5mg | Caps. | Synthon Hispania, S.l. - Spania | L04AX04 | 📄 Prospect |
| LENALIDOMIDA STADA 10 mg | 10mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA STADA 15 mg | 15mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA STADA 2,5 mg | 2,5mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA STADA 20 mg | 20mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA STADA 25 mg | 25mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA STADA 5 mg | 5mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA STADA 7,5 mg | 7,5mg | Caps. | Pharmadox Healthcare Ltd. - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDA TERAPIA 10 mg | 10mg | Caps. | Sun Pharmaceutical Industries Europe B.v. - Olanda | L04AX04 | 📄 Prospect |
| LENALIDOMIDA TERAPIA 15 mg | 15mg | Caps. | Sun Pharmaceutical Industries Europe B.v. - Olanda | L04AX04 | 📄 Prospect |
| LENALIDOMIDA TERAPIA 20 mg | 20mg | Caps. | Sun Pharmaceutical Industries Europe B.v. - Olanda | L04AX04 | 📄 Prospect |
| LENALIDOMIDA TERAPIA 5 mg | 5mg | Caps. | Sun Pharmaceutical Industries Europe B.v. - Olanda | L04AX04 | 📄 Prospect |
| LENALIDOMIDA TERAPIA 7,5 mg | 7,5mg | Caps. | Sun Pharmaceutical Industries Europe B.v. - Olanda | L04AX04 | 📄 Prospect |
| LENALIDOMIDA TEVA 10 mg | 10mg | Caps. | Teva Operations Poland Sp. Z.o.o - Polonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA TEVA 15 mg | 15mg | Caps. | Teva Operations Poland Sp. Z.o.o - Polonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA TEVA 20 mg | 20mg | Caps. | Teva Operations Poland Sp. Z.o.o - Polonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDA TEVA 5 mg | 5mg | Caps. | Teva Operations Poland Sp. Z.o.o - Polonia | L04AX04 | 📄 Prospect |
| LENALIDOMIDE ACCORD 10 mg | 10mg | Caps. | Pharmadox Healthcare Limited - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDE ACCORD 15 mg | 15mg | Caps. | Pharmadox Healthcare Limited - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDE ACCORD 2,5 mg | 2,5mg | Caps. | Pharmadox Healthcare Limited - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDE ACCORD 20 mg | 20mg | Caps. | Pharmadox Healthcare Limited - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDE ACCORD 25 mg | 25mg | Caps. | Pharmadox Healthcare Limited - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDE ACCORD 5 mg | 5mg | Caps. | Pharmadox Healthcare Limited - Malta | L04AX04 | 📄 Prospect |
| LENALIDOMIDE ACCORD 7,5 mg | 7,5mg | Caps. | Pharmadox Healthcare Limited - Malta | L04AX04 | 📄 Prospect |
Clase ATC asociate
Substanțe active cu acțiune similară
Alte DCI-uri din aceeași clasă terapeutică: